The Draft National Health Research Policy 2026 establishes a unified framework to transform India's medical research. It targets increasing public investment to 0.15% of GDP, enhancing disease-burden aligned indigenous innovation, and implementing a three-tier governance ecosystem for public health.
Click to View MoreGenerative AI is increasingly embedded in healthcare systems to address workforce shortages, improve efficiency, support clinical decision-making, and accelerate medical research. While it offers significant benefits in documentation, diagnostics, patient engagement, and drug discovery, its adoption raises concerns related to accuracy, bias, data privacy, ethics, and regulation. The future of Generative AI in healthcare therefore depends on responsible governance, strong government initiatives, and human oversight to ensure that technology augments, rather than replaces, clinical judgement and patient trust.
Click to View MoreNeurotechnology—ranging from brain-computer interfaces to neural stimulation—offers India major gains in health, innovation, and economic growth by improving treatment for neurological disorders, enabling assistive devices, and creating new tech industries. Globally, countries like the U.S., China, and Chile are advancing neurotech while shaping ethical norms and neurorights. However, its promise depends on strong regulation that safeguards mental privacy, autonomy, equity, and long-term safety. If India builds research capacity, industry linkages, and ethical oversight,
Click to View More
© 2026 iasgyan. All right reserved
